In clinical trials, insulin analogs modestly reduced the risk of nocturnal hypoglycemia, or low blood sugar during sleep, compared with human insulin. “The problem is that insulin analogs are much ...

More people are using insulin to control Type 2 diabetes, and most of those people are using newer analog forms. But patients pay more out of pocket for these drugs, a study finds.

Kirsty is biosimiler to Novolog. It is a rapid-acting human insulin analog indicated to improve glycemic control in adults ...

These insulin analogs had to go the standard FDA required trials to demonstrate safety and efficacy, just like any other experimental medicine. As is the norm, these new drugs were patented.

Background: Although insulin analogues are commonly prescribed for the management of diabetes mellitus, there is uncertainty regarding their optimal use. We conducted meta-analyses to compare the ...

The drug at the heart of the studies is called icodec, an insulin analog with a half-life of 196 hours – a little over eight days. Developed by Novo Nordisk, ...

Insulin analogs have also been shown to improve patients’ health-related quality of life (QOL) relative to human insulins. 41,42 Because QOL is an important determinant of adherence, ...

It's worthwhile to resurrect a 2015 infographic from the Alliance of Community Health Plans that shows which insulin analogs are spiking most in price. By Meghana Keshavan on April 05, 2016 7:10 pm.

Analog insulin use predominated and accounted for more than 80% of total treatment visits across all years In 2016, newer insulins were used in 18.1% of total treatment visits and rose in ...

Woman-Diabetes-Insulin_G_645403776 Compared with human neutral protamine Hagedorn insulin, basal insulin analogs do not reduce risk of hypoglycemia-linked ED visits or hospital admissions in T2D.

For patients with type 2 diabetes, the risk of acute myocardial infarction (AMI) is not significantly different for long-acting insulin analogs vs. other basal insulin therapies.

"Technosphere insulin has a unique delivery method, bioavailability, and pharmacodynamics leading to a very different clinical effect per unit compared to rapid-acting analogs." ...